Bavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in Chordoma

    NEXT STORY
    Cybin Inc. (NEO: CYBN) Looking to Solve Long-Standing Problem with MDD Treatment
    PREV STORY
    Report from the Extraordinary General Meeting of Immunicum AB (publ) on December 18, 2020
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SpringWorks Therapeutics Announces Collaboration with Children’s Oncology Group to Conduct a Phase 2 Clinical Trial of Nirogacestat in Pediatric Patients with Desmoid Tumors and Reports Publication of Nirogacestat Case Series in Pediatric/Young Adult Desmoid Tumor Patients

    author_avatar
    NASDAQ Market News

    Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    Monaghan Medical Corporation Introduces an Intermediate-Size Mask

    author_avatar
    NASDAQ Market News